Yahoo News New York’s Initiative for Medicines, Access & Knowledge (I-MAK), which works to ensure affordable access to drugs, said it opposed the patent for the drug sofosbuvir to treat the liver-destroying disease on the grounds that it is “old science”.
Learn more about how you can help build a more equitable system for all Notice: JavaScript is required for this content.